A Mab A Case Study In Bioprocess Development -

Success in mAb development isn't just about high titers; it's about building a scalable, data-driven process that ensures purity from the very first flask. downstream purification details for your project?

Using tangential flow filtration (TFF) with 30 kDa cassettes, the team concentrates Mab-X from 2 mg/mL to 120 mg/mL. At 100 mg/mL, viscosity reaches 25 cP, causing high pump shear and membrane fouling. A Mab A Case Study In Bioprocess Development